Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.68	12.62	13.16	63.46	16.46	5.15
Short-Term Investments	36.97	14.53	29.14	5.99	27.8	72.83
Cash & Short-Term Investments	41.65	27.15	42.3	69.45	44.26	77.98
Cash Growth	29.48%	-35.82%	-39.09%	56.92%	-43.24%	-31.95%
Accounts Receivable	0.07	0.03	0.59	0.51	-	-
Other Receivables	0.15	0.04	0.05	0.03	0.09	0.33
Receivables	0.22	0.06	0.63	0.54	0.09	0.33
Prepaid Expenses	0.39	0.38	0.43	0.45	0.4	0.31
Other Current Assets	0.66	0.37	0.29	0.87	0.59	0.73
Total Current Assets	42.92	27.96	43.66	71.31	45.34	79.34
Property, Plant & Equipment	0.46	1.39	2.57	3.64	2.55	3.79
Long-Term Investments	15.19	16.12	21.88	34.27	37.23	-
Other Long-Term Assets	0.25	0.09	0.13	0.24	0.41	0.51
Total Assets	58.82	45.55	68.24	109.46	85.53	83.65
Accounts Payable	1.87	1.53	1.98	1.57	3.47	2.45
Accrued Expenses	3.81	3.73	7.39	6.96	7.42	6.62
Current Portion of Leases	0.35	1.37	1.23	1.05	1.08	0.88
Other Current Liabilities	40.37	0.25	0.16	0.12	0.18	0.28
Total Current Liabilities	46.41	6.87	10.75	9.69	12.15	10.23
Long-Term Leases	-	-	1.37	2.6	1.23	2.31
Total Liabilities	46.41	6.87	12.13	12.29	13.38	12.54
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	398.04	374.36	364.36	361.67	295.28	288.22
Retained Earnings	-384.9	-334.72	-307.69	-266.38	-223.14	-217.15
Comprehensive Income & Other	-0.74	-0.97	-0.56	1.87	0	0.03
Total Common Equity	12.41	38.68	56.12	97.16	72.15	71.11
Shareholders' Equity	12.41	38.68	56.12	97.16	72.15	71.11
Total Liabilities & Equity	58.82	45.55	68.24	109.46	85.53	83.65
Total Debt	0.35	1.37	2.6	3.65	2.31	3.19
Net Cash (Debt)	41.3	25.78	39.7	65.8	41.95	74.79
Net Cash Growth	35.50%	-35.08%	-39.67%	56.87%	-43.91%	-34.73%
Net Cash Per Share	0.74	0.54	0.85	1.57	1.42	2.55
Filing Date Shares Outstanding	64.26	49.04	46.57	46.55	38.31	27.95
Total Common Shares Outstanding	62.58	49.04	46.55	46.55	28.37	27.95
Working Capital	-3.49	21.09	32.91	61.62	33.19	69.12
Book Value Per Share	0.20	0.79	1.21	2.09	2.54	2.54
Tangible Book Value	12.41	38.68	56.12	97.16	72.15	71.11
Tangible Book Value Per Share	0.20	0.79	1.21	2.09	2.54	2.54
Machinery	2.71	2.85	2.82	2.62	2.61	2.54
Leasehold Improvements	2.08	2.08	2.08	2.08	2.08	2.08

Source: S&P Capital IQ. Standard template. Financial Sources.